Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dimethyl fumarate may still have a role in progressive multiple sclerosis.

Literature DB >> 27366242

Dimethyl fumarate may still have a role in progressive multiple sclerosis.

Domenico Plantone¹, Floriana De Angelis², Anisha Doshi², Jeremy Chataway².

Abstract

Entities: Chemical Disease

Year: 2016 PMID： 27366242 PMCID： PMC4916520 DOI： 10.1177/1756285616640396

Source DB: PubMed Journal: Ther Adv Neurol Disord ISSN： 1756-2856 Impact factor: 6.570

× No keyword cloud information.

15 in total

1. Perforin-dependent neurologic injury in a viral model of multiple sclerosis.

Authors: P D Murray; D B McGavern; X Lin; M K Njenga; J Leibowitz; L R Pease; M Rodriguez
Journal: J Neurosci Date: 1998-09-15 Impact factor: 6.167

2. Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.

Authors: Katrin Strassburger-Krogias; Gisa Ellrichmann; Christos Krogias; Peter Altmeyer; Andrew Chan; Ralf Gold
Journal: Ther Adv Neurol Disord Date: 2014-09 Impact factor: 6.570

3. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Authors: Robert J Fox; David H Miller; J Theodore Phillips; Michael Hutchinson; Eva Havrdova; Mariko Kita; Minhua Yang; Kartik Raghupathi; Mark Novas; Marianne T Sweetser; Vissia Viglietta; Katherine T Dawson
Journal: N Engl J Med Date: 2012-09-20 Impact factor: 91.245

4. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Authors: Ralf Gold; Ludwig Kappos; Douglas L Arnold; Amit Bar-Or; Gavin Giovannoni; Krzysztof Selmaj; Carlo Tornatore; Marianne T Sweetser; Minhua Yang; Sarah I Sheikh; Katherine T Dawson
Journal: N Engl J Med Date: 2012-09-20 Impact factor: 91.245

Review 5. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.

Authors: Kimmy G Su; Gary Banker; Dennis Bourdette; Michael Forte
Journal: Curr Neurol Neurosci Rep Date: 2009-09 Impact factor: 5.081

6. Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis.

Authors: Domenico Plantone; Alessandro Marti; Giovanni Frisullo; Raffaele Iorio; Valentina Damato; Viviana Nociti; Agata Katia Patanella; Assunta Bianco; Massimiliano Mirabella; Anna Paola Batocchi
Journal: J Neuroimmunol Date: 2013-10-12 Impact factor: 3.478

Dimethyl fumarate may still have a role in progressive multiple sclerosis.

1. Perforin-dependent neurologic injury in a viral model of multiple sclerosis.

2. Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.

3. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

4. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Review 5. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.

6. Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis.

Review 7. CD8(+) T cells in multiple sclerosis.

8. The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis.

9. CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis.

10. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.

Review 1. Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.